Cambridge Investment Research Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,387
Closed -$408K 3752
2025
Q1
$408K Buy
6,387
+358
+6% +$22.9K ﹤0.01% 2623
2024
Q4
$733K Buy
6,029
+632
+12% +$76.8K ﹤0.01% 2111
2024
Q3
$674K Sell
5,397
-934
-15% -$117K ﹤0.01% 2173
2024
Q2
$1M Buy
6,331
+120
+2% +$19K ﹤0.01% 1778
2024
Q1
$804K Buy
6,211
+3,267
+111% +$423K ﹤0.01% 1884
2023
Q4
$284K Buy
2,944
+154
+6% +$14.9K ﹤0.01% 2636
2023
Q3
$338K Buy
2,790
+2
+0.1% +$242 ﹤0.01% 2414
2023
Q2
$319K Buy
2,788
+3
+0.1% +$343 ﹤0.01% 2480
2023
Q1
$384K Buy
2,785
+1,141
+69% +$157K ﹤0.01% 2281
2022
Q4
$213K Sell
1,644
-467
-22% -$60.5K ﹤0.01% 2706
2022
Q3
$233K Buy
+2,111
New +$233K ﹤0.01% 2585
2022
Q1
Sell
-3,265
Closed -$294K 3303
2021
Q4
$294K Sell
3,265
-865
-21% -$77.9K ﹤0.01% 2540
2021
Q3
$382K Sell
4,130
-1,201
-23% -$111K ﹤0.01% 2259
2021
Q2
$414K Buy
5,331
+365
+7% +$28.3K ﹤0.01% 2209
2021
Q1
$370K Buy
4,966
+1,580
+47% +$118K ﹤0.01% 2133
2020
Q4
$577K Sell
3,386
-717
-17% -$122K ﹤0.01% 1677
2020
Q3
$576K Sell
4,103
-99
-2% -$13.9K ﹤0.01% 1522
2020
Q2
$674K Sell
4,202
-863
-17% -$138K 0.01% 1369
2020
Q1
$495K Buy
5,065
+400
+9% +$39.1K ﹤0.01% 1370
2019
Q4
$602K Buy
4,665
+86
+2% +$11.1K ﹤0.01% 1463
2019
Q3
$345K Sell
4,579
-82
-2% -$6.18K ﹤0.01% 1733
2019
Q2
$708K Hold
4,661
0.01% 1231
2019
Q1
$556K Buy
4,661
+495
+12% +$59K 0.01% 1414
2018
Q4
$455K Sell
4,166
-2,227
-35% -$243K 0.01% 1378
2018
Q3
$1.03M Buy
6,393
+2,596
+68% +$419K 0.01% 1008
2018
Q2
$502K Sell
3,797
-6,754
-64% -$893K 0.01% 1396
2018
Q1
$782K Buy
10,551
+5,912
+127% +$438K 0.01% 1073
2017
Q4
$258K Sell
4,639
-1,011
-18% -$56.2K ﹤0.01% 1753
2017
Q3
$256K Buy
+5,650
New +$256K ﹤0.01% 1663